DEKA Biosciences

D3 Bio

This biotechnology company develops precision medicines and oncology therapeutics for patients with cancer and immunological conditions.

Bright Peak Therapeutics

This biotechnology company develops engineered cytokine immunotherapies and immunoconjugates to treat patients with cancer and autoimmune diseases.

Synthekine

This company develops engineered cytokine therapeutics and protein engineering platforms for patients with cancer and autoimmune or inflammatory diseases.

Fore Bio

This biotechnology company develops precision oncology therapies and small-molecule inhibitors for patients with unaddressed tumour mutations and hard-to-treat cancers.

Kymera Therapeutics

This biotechnology company develops small molecule medicines that degrade disease-causing proteins for patients with cancer and immune-inflammatory diseases.

HYKU Biosciences

This biotechnology company develops precision covalent small-molecule medicines targeting disease-driving proteins to treat patients with cancer and other illnesses.

Kanvas Biosciences

This company develops microbiome mapping platforms and live biotherapeutic products for pharmaceutical companies and research institutions focused on treating cancer and inflammatory diseases.

Reverb Therapeutics

This biotechnology company develops bispecific antibody therapies that redirect the body's natural cytokines to treat patients with cancer and autoimmune diseases.